Category: Lifesciences
-
Maravai LifeSciences may be worth $15 to $20 share in a takeout – analyst
•
franckreporter/E+ via Getty Images Maravai Life Sciences (NASDAQ: MROV) could be worth $15 to $20 per share in a potential acquisition based on previous transactions, according to an RBC analyst, after a report that Repligen (RGEN) has made an offer for the vaccine reagent vendor. Maravai Stock (MRVI)) jump 23%…
-
Edwards Lifesciences buys Israeli co Innovalve Bio Medical
•
Edwards Lifesciences (NYSE: EW) today announced that it has exercised its option to acquire an early-stage Israeli transvascular coronary angioplasty company Inovalife Biomedical IndustriesNo financial details were disclosed, but the acquisition is estimated to be worth hundreds of millions of dollars. Innovalve was founded at the Sheba Medical Center in…